Cambridge Investment Research Advisors’s Doximity DOCS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,038	Closed	-$267K	–	3967
2025 Q4	$267K	Sell	6,038 -2,771	-31%	-$156K	﹤0.01%	3316
2025 Q3	$644K	Buy	+8,809	New	+$574K	﹤0.01%	2439
2023 Q4	–	Sell	-21,101	Closed	-$448K	–	3218
2023 Q3	$448K	Buy	+21,101	New	+$576K	﹤0.01%	2175
2022 Q3	–	Sell	-17,744	Closed	-$618K	–	3087
2022 Q2	$618K	Sell	17,744 -3,355	-16%	-$132K	﹤0.01%	1800
2022 Q1	$1.1M	Buy	21,099 +17,021	+417%	+$857K	0.01%	1507
2021 Q4	$204K	Sell	4,078 -2,210	-35%	-$144K	﹤0.01%	2881
2021 Q3	$507K	Buy	+6,288	New	+$460K	﹤0.01%	2042

Other funds holding DOCS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cambridge Investment Research Advisors's DOCS Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Doximity (DOCS) in Q1 2026, closing a stake of 6,038 shares — an estimated $267K sold.

Cambridge Investment Research Advisors first reported a position in DOCS in Q3 2021 and held it in 7 quarters. The position peaked at $1.1M in Q1 2022. 423 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

Cambridge Investment Research Advisors reported no remaining Doximity position as of Q1 2026 after selling out during the quarter.
Cambridge Investment Research Advisors sold 6,038 Doximity shares in Q1 2026, an estimated $267K.
Cambridge Investment Research Advisors first reported a position in Doximity in Q3 2021 and held it in 7 quarters.
Cambridge Investment Research Advisors's Doximity position peaked at $1.1M in Q1 2022.
423 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.